NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis

Lumexa Imaging Holdings, Inc. (LMRI) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

LMRI

$10.81

+$0.13 (+1.22%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LMRI with… →

LMRI Key Statistics

As of Oct 21, 2026
Trading
Open
$10.67
Previous Close
$10.68
Day's Range
10.66–11.12
52-Week Range
6.45–19.45
Volume
315.23K
Valuation
Market Cap
$1.04B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
12.14
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.00
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.37
Financials (FY)
Revenue (FY)
$1.02B+7.82%
Net Income (FY)
−$47.10M
Profit marginThe share of revenue left as profit after all costs and taxes.
−2.66%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
96.07M
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
409.96K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Lumexa Imaging Holdings, Inc. (LMRI) has a market capitalization of $1.04B.

In fiscal 2025, LMRI reported revenue of $1.02B.

LMRI Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−41.57%
2025 (partial year)−0.11%

As of October 21, 2026.

LMRI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.02B−$47.10M−4.6%
2024$948.87M−$94.10M−9.9%
2023$935.93M−$122.23M−13.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.02B$157.57M$26.73M−$47.10M−4.6%
2024$948.87M$96.26M−$16.26M−$94.10M−9.9%
2023$935.93M$98.97M−$12.83M−$122.23M−13.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LMRI Valuation vs Medical Devices Median

Median of 145 stocks
MetricLMRIMedical Devices medianvs median
P/S ratio1.002.5361% below
Profit margin−2.66%−14.78%12.1 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Lumexa Imaging Holdings, Inc. (LMRI) at $1.04B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 5,000.

The most recent close on file for LMRI is $10.81, dated October 21, 2026. That is +$0.13 (+1.22%) against the previous close. Over the past 52 weeks the price has ranged from $6.45 to $19.45. The latest close sits 67.6% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.02B. That is +7.82% against the prior fiscal year, when revenue was $948.87M. The same year closed with a net loss of $47.10M. The reported profit margin is −2.66%. That is 12.1 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are −0.37.

Across the 3 fiscal years on file, revenue moves from $935.93M in 2023 to $1.02B in 2025. Of those 3 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 12.14. The price-to-sales ratio is 1. On price-to-sales that is 60.65% below the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The stored price history starts on December 11, 2025, and the total return since then is −41.63%.

Growth & Income

The record shows no dividend for LMRI.

So far in 2026 the total return is −41.57%.

Peer Comparison

Lumexa Imaging Holdings, Inc. (LMRI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Lumexa Imaging Holdings, Inc. LMRI $1.04B —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Lumexa Imaging Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Visit website →